LONG-TERM USE OF BENZODIAZEPINES IN PATIENTS WITH AND WITHOUT PERSONALITY DISORDERS
Scindeks Assistant SCIndeks Assistant
PDF

How to Cite

1.
Žikić O, Kostić J, Stojanov J, Binić I, Nikolić G. LONG-TERM USE OF BENZODIAZEPINES IN PATIENTS WITH AND WITHOUT PERSONALITY DISORDERS. АММ [Internet]. 2025 Feb. 4 [cited 2026 Sep. 20];63(4). Available from: https://test.aseestant.ceon.rs/index.php/amm/article/view/49320

Abstract

Personality disorders (PD) are prevalent co-morbid conditions among addicted individuals. Our study aimed to determine whether long-term, continuous use of benzodiazepines (over a year) leads to the development of symptoms of dependence considering the presence or absence of personality disorders. The group consisted of 78 benzodiazepine users who used benzodiazepine as a monotherapy for at least 1 year before a screening. Patients completed a group of questionnaires: a semi-structured questionnaire for sociodemographic data as well as for basic data on the use of benzodiazepines, Wisconsin Personality Inventory, and Benzodiazepine Dependence Self-Report Questionnaire. The group was divided into two subgroups: the group of subjects with personality disorders (60.26%) and those without personality disorders (39.74%). These two groups were mutually compared concerning: (a) correlates of benzodiazepine dependence (problematic use of benzodiazepines, preoccupation with benzodiazepines, lack of compliance, and withdrawal syndrome) and (b) intensity of benzodiazepine dependence. In the whole group, approximately 70% of subjects had positive indicators for physical dependence (lack of compliance due to a rise of tolerance in 73.08% and withdrawal in 70.51% of subjects). The psychological dependence indicator (preoccupation with benzodiazepines) was positive in 94.87% of subjects, as well as for social aspects of dependence (problematic use of BDZs) in 93.59%. The total score, or intensity of benzodiazepine dependence, was statistically higher in the group with personality disorder. Patients with a personality disorder had more frequent and more intensive preoccupation with benzodiazepine and lack of compliance. Co-occurrence of two or more personality disorders increases the intensity of preoccupation with a benzodiazepine. 

Keywords

benzodiazepine, dependence, personality, withdrawal

References

Andrews G. Comorbidity and the general neurotic syndrome. The British Journal of Psychiatry 1996;168(S30):76-84. [CrossRef][PubMed]

Baillie AJ, Mattick RP. The benzodiazepine dependence questionnaire: development, reliability and validity. The British Journal of Psychiatry 1996;169(3): 276-81. [CrossRef][PubMed]

Canham SL, Gallo J, Simoni-Wastila L. Perceptions of benzodiazepine dependence among women age 65 and older. Journal of gerontological social work 2014;57(8):872-88. [CrossRef][PubMed]

de las Cuevas C, Sanz E, de la Fuente J. Benzodiazepines: more" behavioural" addiction than dependence. Psychopharmacology 2003;167:297-303. [CrossRef][PubMed]

Edinoff AN, Nix CA, Hollier J, Sagrera CE, Delacroix BM, Abubakar T, et al. Benzodiazepines: uses, dangers, and clinical considerations. Neurology international 2021;13(4):594-607. [CrossRef][PubMed]

Fraser R, Isaif L, Teles D, Laporte L. Personality Disorders and Addiction Disorders. In: el-Guebaly N, Carra G, Galanter M, Baldacchino AM, editors. Textbook of Addiction Treatment: International Perspectives. New York City: Springer; 2021. p. 1373-89. [CrossRef]

Goretti S, Sanchéz MS, Borja PL, Rivera GB, Lara MR. The relationship between personality disorders and substance abuse disorders. European Psychiatry 2017;41(S1):S473-4. [CrossRef]

Kan CC, Breteler MH, Timmermans EA, Van der Ven AH, Zitman FG. Scalability, reliability, and validity of the benzodiazepine dependence self-report questionnaire in outpatient benzodiazepine users. Comprehensive psychiatry 1999;40(4):283-91. [CrossRef][PubMed]

Klein MH, Benjamin LS, Rosenfeld R, Treece C, Husted J, Greist JH. The Wisconsin personality disorders inventory: Development, reliability, and validity. Journal of Personality Disorders 1993;7(4):285-303. [CrossRef]

Konopka A, Wysiecka JP, Samochowiec J. Benzodiazepine misuse and addiction. Risk factors and adverse behavioral aspects. In: Preedy VR, editor. Neuropathology of drug addictions and substance misuse, Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. Cambridge (Massachusetts): Academic Press; 2016. p. 327-33. [CrossRef]

Manthey L, Lohbeck M, Giltay EJ, Veena T, Zitman FG, Penninx BW. Correlates of benzodiazepine dependence in the Netherlands Study of Depression and Anxiety. Addiction 2012;107(12):2173-82. [CrossRef][PubMed]

Nordfjærn T, Bjerkeset O, Moylan S, Berk M, Gråwe RW. Clusters of personality traits and psychological symptoms associated with later benzodiazepine prescriptions in the general population: The HUNT Cohort Study. Addictive Behaviors 2013;38(10):2575-80. [CrossRef][PubMed]

Petursson H, Lader MH. Benzodiazepine dependence. British Journal of Addiction 1981;76(2):133-45. [CrossRef][PubMed]

Salzman C, Balter M, Ellinwood E, Gallant DM, Gillin JC, Greenblatt DJ, et al. American Psychiatric Association task force on benzodiazepine dependency, toxicity, and abuse. Washington: American Psychiatric Press; 1990.

Schneider Jr R, Ottoni GL, Carvalho HW, Elisabetsky E, Lara DR. Temperament and character traits associated with the use of alcohol, cannabis, cocaine, benzodiazepines, and hallucinogens: evidence from a large Brazilian web survey. Brazilian Journal of Psychiatry 2015;37:31-9. [CrossRef][PubMed]

Schweizer E, Rickels K, De Martinis N, Case G, Garcia-Espana F. The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patients. Psychological Medicine 1998;28(3):713-20. [CrossRef][PubMed]

Smith TL, Klein MH, Benjamin LS. Validation of the Wisconsin personality disorders inventory-IV with the SCID-II. Journal of Personality Disorders 2003;17(3):173-87. [CrossRef][PubMed]

Uhlenhuth EH, DeWit HA, Balter MB, Johanson CE, Mellinger GD. Risks and benefits of long-term benzodiazepine use. Journal of Clinical Psychopharmacology 1988;8(3):161-7. [CrossRef][PubMed]

Umbricht A, Velez ML. Benzodiazepine and nonbenzodiazepine hypnotics (z-drugs): the other epidemic. In: el-Guebaly N, Carra G, Galanter M, Baldacchino AM, editors. Textbook of Addiction Treatment: International Perspectives. New York City: Springer; 2021. p. 141-56. [CrossRef]

Votaw VR, Geyer R, Rieselbach MM, McHugh RK. The epidemiology of benzodiazepine misuse: a systematic review. Drug and alcohol dependence 2019;200:95-114. [CrossRef][PubMed]